5 results about "Hormone regulation" patented technology

The application of the autologous dendritic cell in preparation of the medicine for treating the nerve injury erectile dysfunction can well promote recovery of the erectile function, perform staged reinfusion, induce immune regulation, repair nerve and blood vessel functions and improve a sex hormone regulation pathway. And the autologous dendritic cells are derived from a user, and have the advantages of safety, effectiveness and convenience in use. The combined immune cell therapy is obviously superior to a single treatment path in efficacy, is also more suitable for chronic, non-structural, subclinical and other ED people which are difficult to intervene by traditional methods, and has stronger individual adaptation ability and long-term controllability at the same time. Compared with a traditional scheme, the cell therapy targeting is better, and the treatment effect is faster.

This invention discloses an Equoluxe multivitamin tablet containing a natural hormone regulator and its preparation process, belonging to the field of pharmaceutical technology. The invention comprises the following formula in parts by weight: 80-100 parts soybean extract, 20-55 parts plant-based lactic acid bacteria, 5-10 parts ginseng extract, 80 parts ginger extract, and 10-30 parts excipients. This invention, through a specific combination, works synergistically to promote estrogen secretion in women, enhance ovarian function, and maintain hormonal balance. By microencapsulating the plant-based lactic acid bacteria during pretreatment, this invention significantly improves the activity retention rate during tableting and storage, achieving an activity retention rate of over 87% after 6 months under accelerated conditions, thus solving the technical problem of poor stability in probiotic products. This invention employs a gradient mixing and low-temperature pressing process to avoid local aggregation of highly active ingredients and high-temperature inactivation, ensuring the uniformity of content and bioavailability of key components such as equoluxone and lactic acid bacteria in the tablets.

The invention belongs to the field of animal breeding, and particularly relates to a traditional Chinese and Tibetan medicine composition for improving the oestrus rate of yaks. The technical problems that the yak is low in oestrus rate and difficult to regulate and control, and hormone regulation and control are large in side effect are solved. According to the specific technical scheme, the pharmaceutical composition comprises gymnadenia conopsea, herba epimedii, angelica sinensis, leonurus, hucho taimen, fructus lycii, prepared rehmannia root, ligusticum wallichii, bighead atractylodes rhizome, mango kernel, fructus chebulae and rhizoma acori calami. According to the prescription provided by the invention, through reasonable compatibility of monarch, minister, assistant and guide, the reproductive system of the yak is adjusted from multiple aspects, the renal function is enhanced, the blood circulation of reproductive organs is improved, nutrient absorption is promoted, and the overall health state is enhanced, so that the aim of promoting oestrus and hybridization of the yak is achieved.

The invention provides a method for regulating and inducing conception of non-pregnant non-oestrus dairy cows. The method is characterized by comprising the following steps: 1) detecting LH and FSH levels and performing staging; 2) carrying out regulation and targeted induction on cows with different LH and FSH stage levels; and 3) artificial insemination. Targeted treatment and precise regulation and control are achieved for high-difficulty breeding cases of 37 sky huai, no oestrus, lasting corpus luteum and uterus residues. The prostaglandin PGF2a + oxytocin + gonadotropin releasing hormone GnRH combined intramuscular injection scheme is adopted, lasting corpus luteum is thoroughly dissolved, residual embryonic tissues in the body are removed, the uterus is purified, the subsequent conception environment quality is remarkably improved, ultrasonic monitoring does not need to be frequently used, individualized and refined hormone regulation is achieved, the conception rate is remarkably increased, and meanwhile the conception time is shortened. The one-birth double-calf rate is stably improved, and the breeding economic benefits are greatly improved.

This invention discloses a method for off-season hydroponic cultivation of Aralia elata buds based on plant hormone regulation, belonging to the field of hydroponic culture technology. This off-season hydroponic method optimizes the concentration ratio of indolebutyric acid (IBA), gibberellin (GA3), and salicylic acid through orthogonal experiments, combined with standardized branch pretreatment, hormone immersion, and ozone water culture management, to achieve efficient off-season cultivation of Aralia elata buds. This off-season hydroponic culture uses exogenous hormone regulation, optimized for the off-season dormancy characteristics of Aralia elata and the physiological needs of bud growth. It effectively activates the physiological metabolic pathways within the branches, quickly breaking the natural dormancy state, while providing suitable hormone guidance for bud differentiation and growth. This results in uniform bud sprouting and robust growth, solving the problems of late bud break from dormancy, slow bud growth, and large differences in growth vigor among different plants, laying a solid foundation for efficient off-season hydroponic production.